Itraconazole (Itrazole) cap 100 mg: Supply issue
Due to manufacturing issues, a supply issue is affecting itraconazole 100 mg capsules (Pharmacode 2354322).
Affected product
Viatris, the supplier, advised that there was an issue at one of its manufacturing plants which means it is out of stock of the following product:
Itraconazole
- Brand: Itrazole
- Presentation: Cap 100 mg
- Pharmacode: 2354322
- Subsidy: $6.83
- Measure / Qty: per 15
Alternative product
Itraconazole Crescent (listed 1 May 2025)
To ensure people can continue to access treatment, we listed a second alternative brand of itraconazole. It is a 15 pack (like the Itrazole)
- Brand: Itraconazole Cresent
- Pharmacode: 2705109
- Subsidy: $6.83
- Measure / Qty: per 15
This product is not Medsafe-registered and will need to be prescribed and dispensed in line with section 29 and 29A of the Medicines Act.
- Unapproved Medicine flier A5 [PDF 131 KB]
Prescribing and supplying an unapproved medicine
Section 29A of the Medicines Act 1981 says medicines that are not Medsafe approved to be prescribed and supplied to people when there is a supply issue. Any prescriber, working within their scope of practice, can prescribe a medicine under section 29A.
We know supplying an unapproved medicine is not ideal. In this case, however, this will allow people to continue to access an appropriate treatment.
We apologise for any inconvenience this causes.
What patients need to know about unapproved medicines – Healthify website(external link)
Resupply expected late 2026
Viatris advises that it doesn't expect the Itrazole brand of itraconazole will be available again before the second half of 2026.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)